EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review

Nazish Naseem, Poonam Kushwaha, Faheem Haider

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-01 · 398 (1) · 449-468

DOI: 10.1007/s00210-024-03408-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 28.08.2024. Verfasst von Nazish Naseem und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Integral University, Dasauli-Kursi Road, Lucknow, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Lipids, Antineoplastic Agents, Nanostructures. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 126 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer, characterized by uncontrolled cell growth and proliferation, continues to be a major global health concern. Breast cancer, the most commonly diagnosed cancer among women, remains a leading cause of cancer-related deaths worldwide. Conventional treatment modalities such as surgery, radiation, and chemotherapy have made significant strides in improving patient outcomes. However, these approaches often face challenges such as limited efficacy, systemic toxicity, and multidrug resistance. Nanotechnology has emerged as a promising avenue for revolutionizing cancer therapy, offering targeted drug delivery, enhanced efficacy, and reduced side effects. Among the various nanocarrier systems, nanostructured lipid carriers (NLCs) have gained considerable attention for their unique advantages. Comprising a blend of solid and liquid lipids, NLCs offer improved drug loading capacity, enhanced stability, sustained release, and biocompatibility. This manuscript provides a comprehensive overview of the role of NLCs in breast cancer management, covering their formulation, methods of preparation, advantages, and disadvantages. Additionally, several studies are presented to illustrate the efficacy of NLCs in delivering anticancer drugs to breast tumors. These studies demonstrate the ability of NLCs to enhance drug cytotoxicity, improve tumor suppression, and minimize systemic toxicity. This manuscript aims to contribute to the existing literature by consolidating current knowledge and providing insights into the future directions of NLC-based therapeutics in breast cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLipidsAntineoplastic AgentsNanostructuresDrug CarriersDrug Delivery SystemsHumansFemaleAnimals

Stichwörter der Autor:innen

BiocompatibilityBreast cancerCancerChemotherapyNanostructured lipid carriers (NLCs)Therapeutic efficacy

Substanzen

LipidsAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Faculty of Pharmacy, Integral University, Dasauli-Kursi Road, Lucknow, India.
  • Faculty of Pharmacy, Integral University, Dasauli-Kursi Road, Lucknow, India. poonam.kushwaha083@gmail.com.

Zitieren

APA

Naseem, N., Kushwaha, P., & Haider, F. (2025). Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(1), 449-468. https://doi.org/10.1007/s00210-024-03408-w

Vancouver

Naseem N, Kushwaha P, Haider F. Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(1):449-468. doi:10.1007/s00210-024-03408-w

BibTeX
@article{Naseem2025,
  author = {Naseem, Nazish and Kushwaha, Poonam and Haider, Faheem},
  title = {Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {1},
  pages = {449--468},
  doi = {10.1007/s00210-024-03408-w}
}
Kostenlos starten →